The sessions, which are delivered by the company's territory managers and cover things like toxicology, ophthalmology and the management of epilepsy, will now be streamed live to computers, tablets or smart phones.
Product Manager Will Peel (pictured right) said: "We know that concerns over coronavirus are affecting our customers so we want to make it as easy as possible for them to benefit from the information imparted in our Lunch and Learn sessions while normal service is disrupted.
‘We hope that these measures will also help us offer more virtual workshops in the future to make our sessions more accessible for busy veterinary staff and we are looking at the possibility of organising virtual drop ins from our sales team in the future.’
For more information visit: https://www.tvm-uk.com. To rearrange a previously booked session contact your local territory manager or email help@tvm-uk.com.
The term ‘evidence synthesis’ describes a range of methodological approaches used to systematically review, appraise, and summarise evidence on a specific area.
The approaches differ from conventional literature reviews or narrative reviews, which are not required to have a specified search strategy or methodology for appraising evidence, and usually present a personal perspective or opinion.
There are three main types of evidence syntheses: rapid reviews, systematic reviews, and scoping reviews.
All have key principles in common, which includes the formulation of a structured question, a systematic search of the available literature, a defined process of reviewing and selecting suitable publications, and a methodology for analysing the final included evidence.
Evidence synthesis is still not widely used in the equine veterinary world, despite its recognised value in human evidence-based medicine.
In the new virtual collection, the EVJ discusses the what and the why of this important evaluation method, as well as providing free access to all the equine veterinary evidence reviews published to date, including:
“Evidence synthesis makes an important contribution towards generating the evidence base which underpins equine clinical practice,” said Professor Sarah Freeman. “The challenge compared to human medicine is that equine veterinary data sets are much smaller, and study approaches and methodologies often vary significantly which means that it may not be possible to combine or collate data sets.
“Given this shortfall, scoping reviews can be helpful to identify what information is out there, find areas where a systematic review could be performed, and provide a useful summary for all the studies in a particular area.”
Professor Celia Marr, Editor of the EVJ said: “As increasing numbers of evidence syntheses are published, they will expand our understanding of the current bodies of evidence in veterinary medicine.
“The existing studies are already informing us on how we use evidence in our practices and policies, and it is encouraging to anticipate how they will shape our development of future research, to generate the best evidence as the norm, in every case.”
The virtual issue can be found at https://beva.onlinelibrary.wiley.com/doi/toc/10.1001/(ISSN)2042-3306.evidence-synthesis-collection
The association says that its research has found that 94% of companion animal vets say they have clients who feed a raw diet, 42% who feed meat-free diets and 29% who feed insect-protein in place of meat.
However, 6 in 10 vets are unsure how many of the cats and dogs they see are fed meat-free diets.
In a new policy position, the BVA is now urging vets to talk to all cat and dog owners about what they feed their pet, and record nutritional histories and any resulting issues on their practice systems.
BVA President Anna Judson said: “We know that owners of cats and dogs are increasingly drawn to pet diets that reflect their own personal values and lifestyle choices, and this is leading to a surge in alternative approaches to pet food.
"We support owners making informed choices about what to feed their pets, but they must be aware that these choices play a pivotal role in the health of the animal and can also have a wider impact on human health and environmental sustainability.
“One of the key issues in these conversations is the lack of long-term, evidence-based research.
"If vet teams are to maintain our position as the ‘trusted voice’ in these conversations, it’s vital that we ask the right questions and also record as much data as possible so that we can understand the long-term impact of some of these newer diets.”
The BVA says its new policy position is not trying to dictate the ‘best’ diet for individual pets but to support pet owners in meeting their pets’ nutritional needs as well as meeting their own lifestyle choices.
The BVA is also recommending changes to veterinary education to include a new emphasis on the importance of nutrition in day one competencies for vets and nurses, and improved awareness of the need for supportive conversations with animal owners.
To support the profession, the BVA says it will create a new public facing resource and lobby for better labelling of pet food and better labelling and traceability of the animal by-products that represent one of the major sources of protein in many cat and dog foods.
Anna added: “The issues around pet food are complex and with so much information available to pet owners from breeders, friends, online forums and other sources, we want to support all members of the vet team to feel fully confident in guiding their clients through dietary decisions.
"We hope that these recommendations and our upcoming resources will improve the information available to both clients and vets, supporting owners to make healthy, informed choices for their pets.”
https://www.bva.co.uk/take-action/our-policies/diet-choices-for-cats-and-dogs
VetSurgeon.org member Aubrey Kumm MRCVS, a Joint Partner at Companion Care in Harlow, has become one of the first vets based in the UK to gain the GPCert(Endo) from the ESVPS. He joins a group of just 11 vets who currently hold this certificate in Europe.
Aubrey said: "Although there are over 50 veterinary surgeries offering specialist endoscopic surgery in the UK I wanted to ensure I was as well versed as possible in the latest developments of this method of surgery and the ESVPS certificate offered a comprehensive course, the benefits of which I am now able to pass on to clients."
Aubrey's qualification involved a year of study and several examinable components including case studies and a written exam.
The practice has invested around £60,000 in a Force Triad and two laprascopic cameras, along with various operating scopes, a broncoscope,and other associated equipment.
Aubrey added: "As a practice we are now able to offer less invasive surgery to our clients and their pets and we no longer have to ask clients to travel to distant referral centres."
BCF Technology has launched the Mindray DP-50 veterinary ultrasound system, a black and white entry level system that can be used in both the small animal and equine general practice.
According to the company, the DP-50 offers excellent black and white abdominal and cardiac images and the menu system for performing measurements, calculations and image review is very intuitive. The system allows you to save images and video clips to internal memory, as well as exporting to USB.
Nigel Perry from BCF said: "This is an excellent entry level system that provides high quality images at a great price - only £6,500 for the system including one probe. The Mindray DP-50's easy to use menu system and superb image makes this scanner such a useful tool for a general veterinary practice."
Angus McPherson from Lomond Hills Veterinary Practice in Fife said: "We were looking for a scanner that was mobile, easy to use and most importantly gave a good image. The scanner was delivered at 9.00am and by 9.30am we had used it on two dog cases. One with a pyometra and one with an enlarged abdomen."
The DP-50 is exclusively available through BCF. For more information, call +44 (0)1506 460 023 or visit www.bcftechnology.co.uk.
Virbac has announced the launch of a new support pack to help practices promote National Microchipping Month this June.
The pack contains a range of promotional and educational items including:
Sarah Walker MRCVS, BackHome Product Manager, said: "With microchipping soon to become compulsory for dogs across the UK, this year's National Microchipping Month is the ideal platform to raise awareness of its importance in all species and to remind clients that they will soon be required by law to ensure that their dogs at least are protected with a microchip. The new BackHome Mini Chip has a 34% smaller needle than our standard needles and this can minimise any stress and discomfort to pets during implantation.
"The resources in our Microchipping Support Pack are bold, colourful and eye-catching. We hope that, with the creative teams that exist within each practice, you can promote National Microchipping Month successfully using imaginative displays and use this opportunity to engage with your clients."
For more information, contact your Virbac Territory Manager.
As part of the package of measures announced by the Chancellor Rishi Sunak in mid-March, businesses in the retail, hospitality, leisure and childcare sectors are eligible for a 100% business rates holiday for a year in England, Scotland and Wales, offering a vital economic lifeline when many may have had to close or operate with reduced turnover and staffing. In Northern Ireland, all businesses are eligible for a three-month business rates holiday covering April, May and June.
However, veterinary practices, many of which have remained open to provide essential care and treatment for pets and production animals, are not eligible for business rates relief, despite the fact that many are high street businesses and a significant proportion of their income comes from retailing medicines, treatments and other pet products.
The BVA says it has heard directly from hundreds of members who now fear for their future, and a recent survey released by the RCVS indicates that a quarter of practices have seen their weekly turnover reduced by 75%, and about 66% have seen it halved.
The Association has written to the Treasury and devolved government departments to ask why the veterinary profession has so far been overlooked for financial support, while other high street businesses that remain open including food retailers, hardware stores and pet shops are eligible for rates relief.
It has also mobilised its members to contact their local MPs and devolved parliamentarians with their concerns. Several hundred have already downloaded template letters from the BVA website, and parliamentarians representing a wide cross-section of regions and parties have already pledged their support. Ben Lake, MP for Ceredigion, has also tabled a Parliamentary Early Day Motion (#339) recognising the value of vets and pushing for the profession to be given access to business rates relief.
Daniella Dos Santos, BVA President, said: “The Government has repeatedly given thanks to vets for continuing to maintain animal health and welfare and public health and support the food supply chain in these challenging times. But that makes it all the more disappointing that the profession’s pleas for financial support so far seem to have fallen on deaf ears. Veterinary practices are rightly remaining open to provide 24/7 essential care and fulfilling their duty to maintain animal health and welfare, but many are struggling to stay afloat as they grapple with dramatic reductions in turnover and scaling back their rotas to keep colleagues and clients safe.
"It’s been really heartening to see that parliamentarians across the political spectrum value their local vets’ role in their communities and have offered to put pressure on the Treasury and devolved governments to give practices access to vital financial support. We hope that such a strong and united call will be answered soon, and will continue to urge government to help practices to continue their valuable work in these difficult times."
Sarah Fitzpatrick, Head of Partnerships and Events at BSAVA said: “We’re absolutely delighted to be working in partnership with CVS to support the small animal veterinary profession, through the development and upskilling of veterinary professionals.
"The BSAVA manuals are a go-to vet resource, and by providing this access to CVS they become even more valuable to the community through their use in practice and in consults.”
Joseph Williams, Veterinary Director for the CVS Small Animal Division said: “At CVS we are passionate about giving the best possible care to animals. We take our responsibility seriously to help colleagues to do that, investing in training and through the support given via our Hub Clinical Leadership team.
"BSAVA manuals have long been a trusted reference point for clinical information in our industry. We’re excited to partner with the BSAVA and now, with access to this great resource, every CVS clinician, whether in the consult room, prep room or on a visit, is now just a couple of clicks away from 46 manuals with over 1400 chapters covering all disciplines from anaesthesia to wildlife casualties.’’
According to Intervet, a study undertaken in Germany last summer has proven the efficacy of Butox SWISH at killing the midges responsible for carrying the bluetongue virus, when applied monthly to cattle. The study showed that even brief contact between a midge and hair from a treated animal killed midges rapidly for up to four weeks post-treatment.
The standard dose, applied in the usual way (on the neck and topline of the animal) delivers full-body coverage of Butox SWISH’s deltamethrin, helped partly by its unique micronised formulation. The product is also highly lipophilic which means it binds onto the natural oil secretions of the coat helping to improve coverage.
The trial used six heifers (each weighing around 400kg) treated with 30ml Butox SWISH (the standard fly dose and method of application). Two un-treated heifers were also studied for comparison.
During the five week period, contact between midges and treated hair caused immediate paralysis, and the midges then died at varying intervals depending on contact time and the number of days post-treatment with Butox SWISH. The trial verified the application of Butox SWISH monthly at the standard dose for cattle.
Trial director, Professor Mehlhorn suggested that producers should be prepared to reduce vector contact by removing their breeding habitats and combining this with the use of a knock-down treatment like Butox SWISH, which is the only product of its type which has proven efficacy against midges. Used in conjunction with vaccination, these measures may not stop the disease entering the herd, but will help reduce the spread of disease.
Emily Holbrook MRCVS, Garth Tozer MRCVS, Dr Richard Dixon and Ken Davison MRCVS have all won a Best Practice Employer Award from Novartis Animal Health after glowing nominations from the staff at their practices.
In addition, Katherine Corbett VN from Nine Lives Veterinary Centre won a special new award, worth £500, for the veterinary nurse that in the judges' opinion had best used the opportunities given to her by her boss, Emily Holbrook.
Katherine's first question when told of her win really demonstrates the commitment that veterinary nurses will give a good boss: "Can I spend it on buying one of Kruuse's Buster ICU cages for the practice? Emily has given me so much; I'd love to give something back."
Rachel Smithson, Marketing Manager at Novartis said: "All of our winners were asked what steps they take to ensure a happy team. Their answers were almost unanimous. Empower your staff. Give them responsibility, and if that means accepting the occasional mistake, then do so. Praise them for a job well done. Thank them regularly. Not only will it make your practice a better working environment, but as Katherine demonstrates, your staff will probably go to extraordinary lengths to support you. That translates into a more profitable practice, and higher standards of veterinary care."
The story is covered in full in the August and September editions of Veterinary Practice magazine, downloadable from www.vetsurgeon.org
Sarah Palmer (left) of Novartis Animal Health makes the presentation to head nurse Katherine Corbett and veterinary surgeon Emily Holbrook of Nine Lives Veterinary Practice; behind them are Anne Corbett (receptionist), Lindsay Harrison (nursing assistant), and Laura Steele (veterinary surgeon).
Kenneth Agnew from Novartis Animal Health prepares to present Kenneth Davison with his Best Practice Employer Award, whilst the team toast their boss.
Veterinary Nursing Assistant Abby Brown (left) and Abby Roberts from Novartis Animal Health toast Garth Tozer, Novartis Best Practice Employer Award winner.
Donna Lewis (BVNA), and Novartis Animal Health CEO George Gunn present Dr Richard Dixon with his award.
Ceva Animal Health has added a new module to its Cardio Academy website which will provide practical advice on the management of dilated cardiomyopathy in practice.
The module contains an interactive seminar hosted by leading cardiologist and professor of medicine and cardiology at North Carolina State University, Clarke Atkins. The seminar lasts around 30 minutes, after which you're are invited to answer quiz questions relating to the presentation in return for a CPD certificate.
Small animal product manager, Fraser Broadfoot, said: "Our online Cardio Academy is an extremely popular CPD resource that can be accessed at any time, day or night! By using leading specialists, the interactive seminars provide cutting edge and practical advice on a variety of cardiology subjects. We add a new module every month, so check the website regularly."
To access the Cardio Academy please visit www.cardioacademy.cevalearn.com.
Burgess Excel has announced the launch of a new app for Android and Apple devices called The Fibrevore Handbook.
The free app, which is available from Apple here, and from Google for Android here, contains a guide to the veterinary care of rabbits, guinea pigs and chinchillas:
In addition the Fibrevore Handbook contains links to a range of Academic Articles, CPD courses and information on Burgess Excel and its products.
Burgess says the app will be updated on an on-going basis with further research findings, articles, images and general information
A new study published this month in the Equine Veterinary Journal (EVJ)1 has concluded that toxins from the seeds of the sycamore tree (Acer pseudoplatanus) are the likely cause of Atypical Myopathy (AM) in Europe.
However, to avoid confusion, the authors of the study point out that the American Sycamore (also just called 'the sycamore' in the USA), is a completely different species: Platanus occidentalis. Furthermore, the sycamore found in the UK is also known as the sycamore maple in other countries.
The new research follows on the heels of a study in the USA earlier this year that linked toxins from the box elder tree (Acer negundo) with Seasonal Pasture Myopathy (SPM), the US equivalent of AM2. The discovery marks an important step for the future prevention of this fatal disease.
Atypical Myopathy is a highly fatal muscle disease in the UK and Northern Europe. In ten years, approximately twenty European countries have reported the disease. Incidences tend to occur repeatedly in the autumn and in the spring following large autumnal outbreaks. Horses that develop AM are usually kept in sparse pastures with an accumulation of dead leaves, dead wood and trees in or around the pasture and are often not fed any supplementary hay or feed. SPM is a very similar disorder, prevalent in Midwestern USA and Eastern Canada that is now known to be caused by the ingestion of hypoglycin A, contained in seeds from the box elder tree.
The new European research1 was conducted by an international team led by Dominic Votion, University of Liege and involved 17 horses from Belgium, Germany and The Netherlands, suffering from Atypical Myopathy. High concentrations of a toxic metabolite of hypoglycin A, were identified in the serum of all of the horses. The pastures of 12 of the horses were visited by experienced botanists and the Acer pseudoplatanus, the sycamore maple, was found to be present in every case. This was the only tree common to all visited pastures.
Researchers believe hypoglycin A is the likely cause of both AM in Europe and SPM in North America. The sycamore and the box elder are known to produce seeds containing hypoglycin A and the pastures of the afflicted horses in Europe and the USA were surrounded by these trees.
Hypoglycin-A is found in various levels in the seeds of plants in the genus Acer as well as in various other genera in the family Sapindaceae such as ackee (Blighia sapida). In ackee, hypoglycin-A levels do vary with ripeness of the fruit and, if the fruit is eaten before it is mature, it causes hypoglycaemia to different degrees including a condition called "Jamaican vomiting sickness" (because of ackee's use in Jamaican cooking) and occasionally death in humans.
Researchers at the Universities of Minnesota2 and Liege are continuing their work to try to uncover exactly how the equine disease occurs. Dr Adrian Hegeman of University of Minnesota said: "It is likely that the most important contributing factors to horses becoming poisoned by hypoglycin-A are the availability of seed in the field combined with lack of other feeding options. The seeds from two species of maples (box elder and sycamore maples) that we have tested include significant quantities of hypoglycin-A.
"We know that seeds contain highly variable quantities from seed to seed, even within a single tree. We do not know yet how hypoglycin-A levels vary seasonally, nor do we know how its abundance varies with different levels of stress to the plant, though this may well explain seasonal variability in the occurrence of the malady. It is possible that conditions that stress the plants may contribute to significant seasonal changes in hypoglycin-A levels. At this point we just don't know. It is common held knowledge that trees under stress usually produce more seed."
Dr Jeff Gillman of University of Minnesota said: "Without question, further analysis of the seeds and other tissues from Acer species needs to be performed along with sampling of plant materials over multiple seasons and at various stress levels. Additionally, one cannot rule out more complex explanations for the seasonality of disease occurrence such as: animals may begin feeding on seed materials in response to depletion of more palatable choices under drought conditions; or simple explanations such as high wind events driving seeds into fields. These sorts of explanations for the occurrence of the disease do not depend on botanical variations in toxicity across seasons, sites or stress levels, yet also require consideration.
"Although limited examples are available, the experience of animals at a pasture site might also confer some degree of behavioral resistance to poisoning due to exposure at sub-lethal levels with prior exposure to seeds in the pasture."
Professor Celia Marr, Editor of Equine Veterinary Journal said: "This is an important advancement in our understanding of what causes AM and how it can be prevented. In immediate practical terms owners can take prompt measures to avoid exposing their horses to sycamore seeds this autumn. Where horses are grazing in the vicinity of sycamore trees, it is imperative that they are provided with sufficient supplementary feed as this will minimise the risk that horses might be tempted to ingest seeds containing this toxin. This must be done carefully and leaving wet hay on the ground should be avoided so providing extra carbohydrate feeds may be more practical."
References
Invicta Animal Health has announced that that EquiChek test kits are now validated for use with synovial fluid, having originally been validated for whole blood only.
EquiChek is an animal-side test to assess the level of Serum Amyloid A (SAA) which is a major acute phase protein of inflammation in horses.
Invicta says that it has been shown that SAA levels in synovial fluid are not influenced by arthrocentesis*, which makes SAA an ideal biomarker to measure whilst monitoring or assessing joint function.
The company says this is the first test which is able to provide a visual semi-quantitative result within 15 minutes. The test will display 4 lines for a normal level of SAA and sequentially fewer lines depending on the severity of the inflammation.
Rob Watkins, Managing Director of Invicta, said: "EquiChek has proved to be a useful tool in the ambulatory toolkit. The validation of synovial fluid extends the use by allowing real-time monitoring of lameness and intra-articular therapies. Normally whilst medicating joints, excess synovial fluid is discarded. Now this can be utilised to assist diagnosis or to assess the response to medication."
Invicta will be at Stand A16 BEVA Congress 2013.
For further information see www.invictavet.com/ or ring 01403 791313
Last year BEVA received a national Antibiotic Guardian award from Public Health England in recognition of its work to promote responsible use of antibiotics. It was the only organisation from the veterinary profession to be shortlisted. BEVA launched its Protect ME antimicrobial campaign in 2012 to coincide with European Antimicrobial Awareness day. The Association has launched additional resources each year to facilitate compliance and educate the public about the importance of antimicrobial awareness.
This year, to recognise World Antibiotic Awareness Week (16th to 22nd November, 2016) and European Antibiotic Awareness Day (18th November), BEVA is encouraging members to document their efforts to reduce the use of critically important antibiotics.
To enter for the award, veterinary surgeons need to share practice sales data (in mls) of chosen antibiotics. Practices that document a reduction in antibiotic sales of these drugs will be presented with a BEVA Antibiotic Champion Award to endorse their commitment to responsible use of antibiotics and to help promote public awareness of the campaign. Members are also encouraged to sign up to be antibiotic guardians at www.antibioticguardian.com
Gayle Hallowell, Co-Chair of the BEVA Health and Medicines Committee said: "We are extremely proud of the equine veterinary profession’s commitment to the responsible use of antibiotics. We hope the introduction of our Champion Award will inject new vigour into efforts to continue to reduce the use of our precariously limited antibiotic resources."
To apply for BEVA Antibiotic Champion Award status visit http://www.beva.org.uk/Antibiotic-Champion-Award The BEVA Protect ME toolkit is free to BEVA members and can be downloaded at www.beva.org.uk.
Intervet/Schering-Plough Animal Health has released diagnostic data which the company says indicates that calf scour problems caused by cryptosporidia are on the increase.
A summary of 2010 results from the company's ScourCheck scheme, which identifies infectious scour pathogens in calf faeces, show the protozoan parasite Cryptosporidium parvum being present in 37% of samples.
Intervet/Schering-Plough ruminant veterinary adviser Drew McGurren said: "Ever since we started testing calf faecal samples in the 1990s, rotavirus and cryptosporidia have always been identified as the two main pathogens implicated in infectious scour problems. But the latest data - and feedback from vets in practice - suggest cryptosporidia incidence is on an upward trend.
"Ten years ago our top line reporting used to refer to rotavirus being implicated in around a third of all infectious calf scour problems and cryptosporidia in roughly a quarter. But in 2009, we detected cryptosporidia in 30% of samples. And this year - from the 250 plus faecal samples we have looked at so far - the incidence seems to be even higher."
Drew stressed that scours caused by cryptosporidia are not always confined to housed calves: "Suckler calves between one and two weeks of age can be very susceptible to infection at grass, particularly if conditions underfoot are muddy around ring feeders. Early May has seen quite a lot of rain, and the parasite thrives in damp conditions."
The major source of cryptosporidia is thought to be either adult cows (which act as carriers without showing signs of disease) or infected scouring calves passing the parasite in their faeces. Drew said: "The infectious dose of the organism is very low and if ring feeders are not moved regularly the disease threat that builds up can be very similar to the housed situation. Faecal contamination of feed and water troughs can also be reduced by raising and covering them.
"Cryptosporidiosis in calves is often seen in combination with other diseases, particularly rotavirus. So vaccinating cows against rotavirus with Rotavec-Corona one to three months pre-calving - as well as a sound colostrum feeding regime and maintaining high hygiene standards - can often tip the balance in your favour."
Intervet Schering-Plough says that if cryptosporidia is diagnosed as the problem, parasite replication and excretion can be reduced with Halocur. This is the only product licensed to treat and prevent cryptosporidiosis. Administered orally to calves after feeding (daily for seven days), it can reduce the severity of diarrhoea and prevent the infection spreading to other calves. Treated calves have also been shown to require fewer antibiotic and anti-inflammatory treatments, as well as less rehydration therapy.
Academics from the University of Bristol's School of Veterinary Sciences and the neurology team at Southmead Hospital Bristol have published the results of study examining the use of percutaneous electrical nerve stimulation (PENS) therapy as a treatment for headshaking syndrome in horses.
The authors say that the condition, a neuropathic facial pain syndrome, often leaves affected horses impossible to ride and dangerous to handle, and can result in euthanasia. At present there are no consistently safe and effective methods for the treatment of headshaking in horses, and the condition is estimated to affect between 10,000 and 20,000 horses in the UK.
The study, which is published in the Equine Veterinary Journal (EVJ), aimed to discover whether PENS therapy, developed by Algotec Research and Development Ltd, is safe, effective and sustainable for the management of trigeminal-mediated headshaking in horses.
Seven horses diagnosed with trigeminal-mediated headshaking were recruited to the trial. All procedures were carried out in sedated horses with a needle-prick sized area of skin desensitised with local anaesthetic to help probe insertion. A disposable PENS probe was placed just beneath the skin adjacent to the nerve under ultrasonographic guidance. The nerve was stimulated for 25 minutes following a protocol of alternating frequencies and a perception threshold based on human clinical data. The probe was removed and the procedure repeated on the other side. Three or four treatments were used during the protocol, with treatments being repeated when signs of headshaking recurred.
All horses tolerated the procedure well. Three horses developed a haematoma at the site on one occasion and two had increased clinical signs for up to three days following first treatment. Six horses responded well after the first treatment and returned to ridden work at the same level before headshaking began. Five horses continued to respond to further treatment.
Veronica Roberts, Senior Clinical Fellow in Equine Medicine in the University's School of Veterinary Sciences, who led the study, said: "Headshaking in horses is a major welfare issue and can be a significant cause of distress.
"Although it is clear that further work is required, including increasing the number of cases and refining the treatment procedures, the study shows that PENS therapy should be the first-line treatment for trigeminal-mediated headshakers, which have failed to respond to conservative treatment, such as nose-nets."
Reference
The International Society of Feline Medicine (ISFM) has announced that it will be hosting monthly webinars for veterinary surgeons from January 2016.
ISFM says it has selected highly qualified speakers who are passionate about cats to cover a range of topics, including medicine, surgery, behaviour, anaesthesia and ophthalmology.
The first four webinars will be free and open to both ISFM members and non-members. Thereafter the series will be available exclusively to ISFM members at no extra cost.
To introduce the series, there will be two webinars in January. The first talk, A practical approach to the cat with respiratory distress, will be given on the 12th January by Kieran Borgeat, a European and American Specialist in Veterinary Cardiology.
The second webinar, Vaccination in cats – everything you wanted to know but were too afraid to ask, will be presented by ISFM's Veterinary Director Andy Sparkes, a European and RCVS Specialist in Feline Medicine, on 26th January.
The webinars will also be available to download later to everyone who registers.
For more information and to register for the January webinars visit: www.icatcare.org/vets/webinars.
To become an ISFM member and access future webinars, go to: www.icatcare.org/isfm-membership.
Organisations including British Veterinary Association (BVA) and the Society of Practising Veterinary Surgeons (SPVS) also responded to the consultation on behalf of members.
The College’s Education Department is now in the process of analysing the consultation responses.
Christine Warman, Head of Education at the RCVS, said: "We are very pleased with the number of responses we have received to this consultation which demonstrates what an important issue CPD, and our approach to it going forward, is for the profession. I am also glad that there was a good split of responses between veterinary surgeons and veterinary nurses as it is important we get as wide a range of views as possible from a wide range of individuals. I’d like to thank everyone who took the time to give us their views.
"Over the coming weeks we will be going through each response with a view to preparing proposals on the next steps for our CPD Working Party’s September meeting."
Proposals are expected to go to the Education Committee and to VN Council in October and then to the November meeting of RCVS Council.
Lohmann Animal Health has launched AviPro IBD Xtreme vaccine against Infectious Bursal Disease — also known as Gumboro Disease — in broilers, commercial layers and breeders.
According to Lohmannn, it is highly effective against the vvIBDV (very virulent IBD virus), it breaks through high levels of maternal antibodies, and controls mortality with no loss of flock performance.
Since the 1980s the acute form of IBD has caused significant economic loss to the poultry industries in several countries. The vvIBDV, a more aggressive form first described in Europe in 1986, is now widespread throughout the world and can cause losses of 30-60 per cent in layers and 5-25 per cent in broilers.
Chicks are most susceptible between one and six weeks. Early in their lives they are protected by maternally-derived antibodies (MDAs), but these antibodies will neutralise live IBD vaccines when they are given too early. However, being highly invasive, the AviPro IBD Xtreme vaccine is able to overcome these MDAs so can be given earlier to provide greater protection from an early age.
Exact timing of vaccination depends primarily on the level of MDAs and the breakthrough titre of the vaccine on the one hand, and the virulence of the field virus and infection pressure on the other.
When compared with four of its main competitors in a trial with SPF birds AviPro IBD Xtreme outperformed them. It had the highest number of sero-positive birds, the highest mean ELISA-antibody titre seven days after vaccination and the best protection against clinical symptoms and mortality after a challenge with vvIBDV,” commented Brigitte Othmar, regulatory affairs manager at LAH.
“With the addition of AviPro IBD Xtreme, Lohmann Animal Health has now completed its range of live IBD vaccines and is able to provide its customers with the appropriate solution for any Gumboro problem,” she added.
AviPro IBD Xtreme can be applied via the drinking water or eye-drop and is presented in vials of 1,000 and 2,500 doses.
More information on this vaccine can be found on the Lohmann Animal Health website http://www.lah.de/.
Virbac - manufacturer of Effipro - has launched the 'Flea Free Zones' campaign to help practices fight back against retail competition in the flea control market.
The company says that with an on-pet flea product market estimated to be worth well in excess of £64 million, and an estimated 20 million cats and dogs in the UK, vets are well positioned to improve their revenues and provide excellent customer service, by promoting flea control to all of their customers.
However, according Dr Rachel Crowe, Effipro Product Manager, much of this business is currently going through retail channels: "Many pet owners have become used to purchasing their flea treatment from retail outlets, mainly due to cost, and no longer distinguishing between a brand bought from a vet and one bought from a supermarket.
"As a dedicated veterinary business, Virbac is focussed on supporting and increasing business within veterinary practices. Our 'Flea Free Zones' campaign is a practice support package designed to help promote initial purchase, as well as long-term client loyalty. We know that pet owners often turn to their vet or vet nurse for advice, but then purchase treatments elsewhere.
"With Effipro, practices have the performance of fipronil but at a highly affordable price, and we believe this promotion will help vets grow their share of the flea control market."
The campaign is designed to get clients purchasing flea treatments from their vet and encourage repeat purchases from the practice.
Dr Crowe said: "The beauty of Effipro is that it has a broad range of products, packs and price flexibility. In particular the single pipette from the Practice Pack is proving a very popular point of entry for the owner, especially as an initial trial purchase. Also included in the promotional campaign is an Effipro loyalty scheme, which provides an incentive to keep clients coming back and literature to assist practice staff to answer customer queries about flea control.
"Just one spot-on treatment range also means there is no confusion with POM-V alternatives, so loyalty to Effipro is easier to retain within the practice. And with the added option of purchasing award winning Indorex environmental insecticide spray, clients now have a complete flea control solution available from their vet practice. So with both products being supported by prominent promotional campaigns, there hasn't been a better opportunity than this for vets looking to capture a bigger share of customer spend on flea treatments."
To learn more about Virbac's Flea Free Zones campaign contact your local Virbac territory manager or call Virbac on 01359 243243.
Specifically, remote assessments will make sure that practices are continuing to meet Veterinary Medicines Regulations, the Core Standards of the PSS and other key standards relating to the practice's accreditation type and level.
Mandisa Greene, RCVS President and Chair of the Practice Standards Group, said: “We have introduced these remote assessments as a means of being able to quality assure veterinary practices that are either in the Scheme or who wish to join it, while still making sure that public health is safeguarded and that the burden our face-to-face assessments may place on practices is reduced.
"All our Practice Standards Scheme Assessors will be trained in carrying out remote assessments, and practices that are due an assessment will be given the full details of how it will work in advance, just like if a physical assessment of the premises were taking place.
"In the immediate-term we will be prioritising those practices that were due assessment visits in March, April and May this year which were cancelled due to the nationwide lockdown and they are currently being contacted to make arrangements. We will then start a rolling programme of visits for the other delayed assessments over the next few months. We will aim to give all practices at least one month’s notice before a visit takes place."
In order to help veterinary teams at RCVS-accredited practices understand the changes and its implications, the RCVS has produced a list of anticipated FAQs containing the details of how remote assessments will work. These can be found at: www.rcvs.org.uk/setting-standards/practice-standards-scheme/remote-assessments.
Those with any additional enquiries should contact the RCVS Practice Standards Team on: pss@rcvs.org.uk.
The pack contains species-specific microchipping law guides, a practice registration guide, a cat chipping cheat sheet, flyers about registration and flyers about Identi’s silent microchipping scanner.
The company has also produced three short videos with more information for vet professionals about Identi, what it does, registering microchips and compulsory cat microchipping.
Tammie O’Leary, commercial lead at Identi, said: “From June 10th, it will be compulsory that owned cats in England are microchipped and registered in the same way.
"With these changes imminent, it is important that staff are up to date with the relevant legislation and the potential consequences of pet keepers not adhering to the law.
"identi’s new Practice Pet Protection Pack will provide busy vet professionals with comprehensive information answering a wide range of microchipping questions in a quick and simple format.”
For a copy of the Practice Pet Protection Pack, email: contact@identichip.co.uk
If you're in London before January 6th 2008, the Animal's War exhibition at the Imperial War Museum might be worth a visit. Sponsored by The Kennel Club and PetPartners, the family exhibition explores the remarkable role of animals in conflict from the First World War to the present day using hands-on interactives, photographs, film and sound clips, paintings, touchable sculptures, and memorabilia from the Imperial War Museum collections and private and public lenders from all over the world.